Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease

Cell Immunol. 2014 Jul;290(1):116-9. doi: 10.1016/j.cellimm.2014.06.003. Epub 2014 Jun 18.

Abstract

Behçet's disease (BD) is an autoimmune disease of unknown etiology. Interleukin-28A (IL-28A) promotes immune responses and may participate in the pathogenesis of autoimmune diseases. To examine the role of IL-28A in the pathogenesis of BD, we measured the expression of IFN-γ and IL-17 by IL-28A-stimulated peripheral blood mononuclear cells (PBMCs) from 19 patients with BD and 16 healthy individuals. We found that IFN-γ and IL-17 were undetectable in the sera from BD patients and control subjects. The mRNA expression and protein production of IFN-γ by IL-28A-stimulated PBMCs from BD patients were significantly increased compared to healthy individuals. No significant difference was observed in the mRNA expression and protein production of IL-17 by IL-28A-stimulated PBMCs between BD patients and normal individuals.

Keywords: Behçet’s disease; Cytokine; IL-28A; PBMCs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Behcet Syndrome / immunology*
  • Female
  • Humans
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / blood*
  • Interferon-gamma / genetics
  • Interleukin-17 / biosynthesis
  • Interleukin-17 / blood*
  • Interleukin-17 / genetics
  • Interleukin-4 / blood
  • Interleukins / immunology*
  • Interleukins / pharmacology
  • Leukocytes, Mononuclear / immunology*
  • Male
  • Middle Aged
  • RNA, Messenger / biosynthesis
  • Th17 Cells / immunology
  • Young Adult

Substances

  • interferon-lambda, human
  • IL4 protein, human
  • Interleukin-17
  • Interleukins
  • RNA, Messenger
  • Interleukin-4
  • Interferon-gamma